Summary
In the present series of trials, Adriamycin (ADM) intravesical instillation therapy was found to be effective against tumors of papillary morphology measuring <10 mm in diameter that were of low pathological stage and low histological grade. The rate of complete disappearance increased in proportion to the concentration of ADM and the duration of retention of the drug, although the efficacy rates were almost the same in each trial. On the other hand, side effects on the bladder were reduced when the instilled solution was lower in concentration and the retention time was short.
Similar content being viewed by others
References
Mishina T, Fujiwara T, Miyakoda K, Araki H, Kobayashi T, Saitoh M, Watanabe H (1979) Adriamycin instillation therapy for bladder tumors. Tohoku J Exp Med 127:339
Mishina T, Watanabe H, Kobayashi T, Maegawa M, Nakagawa S (1986) Absorption of anticancer drugs through bladder epithelium. Urology 27:148
Nakagawa S (1990) Fluorescence microscopy on the absorption and disappearance of Adriamycin through the bladder epithelium in the rat. Jpn J Urol 81:1302
Niijima T, Matsumura Y, Kondo K, Katayama Y, Ozaki Y (1975) Intravesical instillation of Adriamycin for the treatment of tumors of the bladder: preliminary report. Acta Urol Jpn 21:233
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohe, H., Watanabe, H., Mishina, T. et al. Intravesical instillation of Adriamycin for bladder tumors. Cancer Chemother. Pharmacol. 30 (Suppl 1), S45–S49 (1992). https://doi.org/10.1007/BF00686941
Issue Date:
DOI: https://doi.org/10.1007/BF00686941